Capricor Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $2.4M | $-18.8M | $-12.9M | $-6.2M | $-8.9M | $-2.1M | $-1.1M | $-1.1M |
| Depreciation & Amortization | $144.2K | $125.7K | $110.9K | $41.9K | $26.9K | $20.3K | $7.5K | $12.9K |
| Depreciation | $95.0K | $85.9K | $62.1K | $32.2K | — | $6.3K | $7.5K | — |
| Amortization | $49.2K | $48.7K | $48.7K | $10.7K | $11.1K | $4.3K | — | — |
| Stock-Based Compensation | $1.7M | $2.0M | $1.6M | $496.9K | $263.6K | $332.3K | $806.3K | $1.1M |
| Net Cash from Operating Activities | $-14.2M | $-14.5M | $-10.8M | $958.6K | $-6.1M | $-2.2M | $-4.6M | $-4.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $32.2K | $192.0K | $129.7K | $162.7K | $56.1K | $13.4K | $2.0K | $2.2K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $5.0M | $-5.2M | — | — | — | $0 | $-2.0K | $-2.2K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $11.6M | $18.6M | — | — | — | $1.2M | $2.3M | $4.5M |
| Net Change in Cash | — | $-2.4M | $-2.5M | $6.3M | $1.6M | $-1.4M | $-2.3M | $202.4K |
| Free Cash Flow | $-14.3M | $-14.6M | $-10.9M | $795.9K | $-6.2M | $-2.2M | $-4.7M | $-4.3M |